Delivery Order SPE2DB20D3103-SPE2DB24FL9G2
Award Date 12/14/23
Potential Completion Date 12/15/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,645.38 firm fixed price contract is for the supply of Micardis HCT 80-25 mg tablets in 30-count units. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Micardis HCT 80-12.5 mg tablets, a cardiovascular medication, valued at $4,209.48. The contract has an ultimate completion date of October 22, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,150.60 firm fixed price contract is for the supply of Micardis HCT 80-12.5 mg tablet medication. This order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. The IDC enables DLA to efficiently procure a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,635.18, is for the delivery of Micardis HCT 40-12.5 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of June 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This is a firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Micardis HCT 80-12.5 mg tablets in unit doses of 30s, with a ceiling value of $5,657.97 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,242.18, is for the supply of Micardis HCT 80-12.5 mg tablet medication. The contract is a firm-fixed price delivery order, with a period of performance through November 8, 2024. No set-aside designation was used for this award. In addition to this delivery order, AmerisourceBergen...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,521.63 fixed-price contract is for the delivery of MICARDIS HCT 40-12.5 mg tablets through November 30, 2023. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Micardis HCT 80-25 mg tablet units, which are used to treat cardiovascular conditions. The contract has a ceiling value of $6,540.14 and an ultimate completion date of July 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant Indefinite...
- This is a $4,993.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Micardis HCT 80-25 mg tablets, a cardiovascular medication, with a completion date of November 29, 2023. The award is not associated with a set-aside program. In addition to this delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,074.51, is for the delivery of Micardis HCT 80-25 mg tablet units over a period ending on May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...